Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
121 results about "Levamisole" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Levamisole, sold under the trade name Ergamisol among others, is a medication used to treat parasitic worm infections. Specifically it is used for ascariasis and hookworm infections. It is taken by mouth.
Special diluent for swine mycoplasmal pneumonia vaccines and preparation method of special diluent
ActiveCN103071151AStrengthen cellsEnhance humoral immune stimulationAntibacterial agentsBacterial antigen ingredientsCholesterolVaccine antigen
Owner:JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
Complex immunopotentiator for grouper
InactiveCN101480488AOvercoming Negative Feedback Inhibition ProblemsImprove the body's immunityPeptide/protein ingredientsAnimal feeding stuffVitamin CLevamisole
The invention relates to a composite immunity intensifier for groupers, which comprises the following components according to weight percentage: 30 to 40 percent of Beta-dextran, 10 to 20 percent of A3 Alpha peptidoglycan, 10 to 20 percent of vitamin C-2- polyphosphate ester, 10 to 20 percent of levomisole, 5 to 10 percent of ginsenoside and 5 to 10 percent of vitamin E. The invention has the advantages that: firstly, the composite immunity intensifier effectively overcomes the problem that the body reverse feedback of the groupers is restrained and can be used in the whole culturing period of the groupers; secondly, the composite immunity intensifier as a feed additive is used in the compound feed of the groupers and only has 0.1 to 0.2 percent of addition amount; thirdly, the body immunity of the groupers is intensified obviously and the survival rate is improved; fourthly, the composite immunity intensifier has no bad effect on the palatability of feed; and fifthly, the raw material used by the composite immunity intensifier has stable source, low price and simple production process.
Owner:GUANGDONG OCEAN UNIVERSITY
Adjuvant used for vaccine and application thereof
ActiveCN106177939ALow costEasy to usePharmaceutical non-active ingredientsImmunological disordersAdjuvantProtein stabilization
The invention provides an adjuvant used for vaccine. The adjuvant comprises alumina gel, levamisole or its derivative, and also polyacrylate. The invention also discloses a vaccine composition containing the adjuvant and an application thereof. The adjuvant can be used as the adjuvant for inactivated vaccine, and also can be used for preparing protein stabilization liquid. The vaccine composition containing the adjuvant can generate humoral immunity for human body and can generate cellular immunity, and can generate good immune response under condition of low antigen content and single immune, and can stabilize protein, degradation and irreversible change cannot be generated.
Owner:PU LIKE BIO ENG
Method used for in vitro amplification of gamma-delta-T cells
InactiveCN103756962AFully stimulatedInhibit apoptosisBlood/immune system cellsPeripheral blood mononuclear cellLevamisole
The invention relates to a method for culturing gamma-delta-T cells, and more specifically relates to a method for in-vitro amplification of gamma-delta-T cells. The method comprises the following operating steps: pre-coating a T75 culture bottle with a TCR-gamma-delta resisting antibody and CD28McAb for later use; isolating peripheral blood mononuclear cells (PBMC) of patients; regulating PBMC concentration to 1*10<6> / ml with a serum-free culture medium which contains 5% of autologous plasma, and transferring the PBMC cell suspension into the T75 culture bottle; adding an initial culture medium which contains proper concentrations of Zoledronat, HSP70, Toll-like Receptors7 (TLR7) ligand, Levamisole (LMS), IL-2, IL-7 and IL-15; culturing in a saturated humid environment containing 5% of CO2 at 37 DEG C; according to growth situation of the cell, changing the culture medium every 2 to 3 days so as to control the cell concentration at about 2.5*10<6> / ml; meanwhile, compensating full doses of Zoledronat, HSP70, Toll-like Receptors7 (TLR7) ligand, Levamisole (LMS), IL-2, IL-7 and IL-15;; and continuously culturing for 12to 16 days so as to obtain a great amount of gamma-delta-T cells which are comparatively high in purity.
Owner:SHANGHAI CLAISON BIOTECH
Vaccine composition, preparation method and application thereof
ActiveCN104248760APlay a role in immune enhancementMaintain stabilityAntiviralsAntibody medical ingredientsLevamisolePolymer
The invention provides a vaccine composition, which comprises an immune amount of a porcine circovirus antigen, an immune amount of a mycoplasma hyopneumoniae antigen, and levamisole or its derivative, and a polymer. The vaccine composition not only can have an immunological enhancement effect on two antigens at the same time, but also has stability, and can be used for dilution of porcine reproductive and respiratory syndrome live vaccines.
Owner:PU LIKE BIO ENG
Compound immunoenhancement agent, vaccine for birds and method for preparing compound immunoenhancement agent
ActiveCN102743750AShorten the immune window periodShort immune windowAntiviralsImmunological disordersBird fluDipeptide
The invention relates to a compound immunoenhancement agent and an application thereof on preparing a vaccine for birds. The compound immunoenhancement agent contains 5ng-10mg / mL of poly IC, 10ng-10mg / mL of muramyl dipeptide, 10ng-5mg / mL of levamisole, 10ng-5mg / mL of resiquimod and 10ng-5mg / mL of imiquimod. After the immunoenhancement agent and H5 hypotype bird flu inactivated vaccine are mixed together, antibody can be produced one week earlier, and the antibody titer is improved above 1.8log2. After chicken are immunized through H5 hypotype bird flu inactivated vaccine, H9 hypotype bird flu vaccine or infectious bronchitis vaccine which contains the compound vaccine immunoenhancement agent, the window phases of the antibody production are shortened, the antibody titer of the vaccine is improved, the immunization duration is prolonged, and the probability of infection disease is reduced.
Owner:南京国创生物技术研究院有限公司
Vaccine adjuvant of swine mycoplasmal pneumonia live vaccine, and preparation method and application thereof
ActiveCN101954079AEnhance immune responseImmune activationAntibacterial agentsBacterial antigen ingredientsPhosphateLevamisole
Owner:JIANGSU ACAD OF AGRI SCI
Complex immunopotentiator for egg-shaped pompano
InactiveCN101480221AOvercoming Negative Feedback Inhibition ProblemsNo adverse effects on palatabilityAnimal feeding stuffAccessory food factorsSelenium methionineAdditive ingredient
The invention relates to a compound immunopotentiator for golden pomfrets, which comprises following ingredients by weight percentages: 20 to 30 percent of beta-dextran, 10 to 20 percent of levamisol, 10 to 20 percent of lentinan, 10 to 15 percent of vitamin A, 10 to 20 percent of vitamin E and 10 to 15 percent of selenium methionine. The invention effectively overcomes the problem of reverse feedback inhibination of golden pomfret organisms, can be used in a complete culture period of the golden pomfrets, is used as a feed additive to be added in golden pomfret feed by only 0.1 percent to 0.2 percent, obviously enhances the organism immunity of the golden pomfrets, improves the live rate, and has no influence on the palatability of the feed; and raw materials used in the compound immunopotentiator have stable resources, low cost and simple production technology.
Owner:GUANGDONG OCEAN UNIVERSITY
Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
This invention relates to antihelminthic pharmaceutical combinations comprising iodinated aromatic compounds, such as disophenol or nitroxynil, with other pharmaceutical active ingredients targeting the treatment of animals. More specifically, this invention concerns pharmaceutical compositions comprising disophenol or nitroxynil with at least one other pharmaceutical antihelminthic active ingredient, selected from among benzimidazoles, thiabendazole, levamisole or tetramisole salts, avermectins or milbemycins and, even more preferably, levamisole salts selected from between levamisole chloride or phosphate.This invention also relates to medications and a method for treating animals comprising such antihelminthic medications.
Owner:OURO FINO SAUDE ANIMAL PARTICIPACOES SA +1
Compound panax ginseng total saponin and levamisole nano emulsion adjuvant and preparation method thereof
InactiveCN101670103AEnhance immune functionImprove immunityOrganic non-active ingredientsEmulsion deliveryTh2 responseLevamisole
The invention discloses a compound panax ginseng saponin and levamisole nano emulsion adjuvant. The adjuvant has the particle diameter of 1-100 nm and comprises panax ginseng saponin, levamisole, a surface active agent, a cosurfactant, oil and distilled water. The product is transparent faint yellow liquid in appearance, and the particle parameter is smaller than 100 nm; the viscosity is lower, and the viscosity requirement of emulsion as a vaccine adjuvant is met; the stability is higher, and the product can be preserved at room temperature or 4 DEG C for a long time; the special emulsification is not needed during seedling preparation, the requirement to equipment is low, and the quality of the product is easy to control. Egg white albumin (OVA) as mode antigen indicates that the compound panax ginseng saponin and levamisole nano emulsion adjuvant can induce better immune reaction than an aluminum adjuvant in a certain dosage, generate higher antibody titer, reduce the dosage of theadjuvant or the antigen, simulate Th1 and Th2 reaction, reinforce the body fluid and cell immunization of an organism and play a role of complete immune protection.
Owner:NORTHWEST A & F UNIV
Nematode-trapping fungus and vermifuge combined medication box and its application
InactiveCN105343879AUse lessPrevent proliferationOrganic active ingredientsFungi medical ingredientsAvermectinLevamisole
The invention belongs to the fields of microbiology and parasitology and provides a nematode-trapping fungus and vermifuge combined medication box. Effective ingredients of a vermifuge are chosen from common antinematodal drugs such as albendazole, ivermectin, avermectin and levamisole; for example, the ratio of an albendazole vermifuge or ivermectin vermifuge to a nematode-trapping fungus, per kilogram of animal body weight is 10-15 mg to 1*106 akinetes or 0.2 mg to 1*106 akinetes. The combined use mode of nematode-trapping fungi and vermifuges is provided to overcome the situation that the nematode-trapping fungi are independently used in China at present while chemical vermifuges cannot be quickly abandoned, after gastrointestinal nematodes are killed and decomposed by the medication, eggs and nematode-trapping fungi are jointly discharged out with excrement, when the eggs develop into larvae, the nematode-trapping fungi are stimulated to generate hyphae trap and network loops to trap the nematodes, thus avoiding the spread of the larvae causing new infections in livestock.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY
Freshwater-shrimp larva feed for enhancing immunity
InactiveCN105851490AImprove immunityEasy to eatFood processingClimate change adaptationBiotechnologyVitamin C
The invention discloses a freshwater-shrimp larva feed for enhancing immunity. The freshwater-shrimp larva feed comprises fish powder, shrimp powder, silkworm chrysalis powder, surimi protein, shellfish meat powder, earthworm powder, peanut cakes, wheat bran, bean dregs, rice bran, aquatic plant powder, corn starch, scallop powder, gelatin, Peru fish oil, soya bean lecithin, hydroxymethyl cellulose, wheat starch, sodium alginate, Zhiqi fungal substances, mineral premixed materials, vitamins C, vitamins E, Chinese herbal medicine immunoenhancement, bacilli, levamisole, selenious yeast, selenomethionine, sodium selenite, potassium diformate, beta-glucose and seaweed polysaccharide. By means of the freshwater-shrimp larva feed, the immunity of freshwater-shrimp larvas can be effectively enhanced, the survival rate of freshwater shrimps is further effectively increased, and the yield and the quality of the freshwater shrimps are increased.
Owner:ANQING WANYIJI CATTLE AQUATIC PROD CULTURE
Mycobacterium tuberculosis ag85ab chimeric gene vaccine, its preparation method and application
ActiveCN102268446AStrong immune responseGood treatment effectAntibacterial agentsBacterial antigen ingredientsAdjuvantLevamisole
The invention provides a mosaic gene, which comprises a gene for coding tubercle bacillus protein Ag85a and a gene which is mosaiced at a Kpn I recognition sequence at sites 245-250 and / or an Acc I recognition sequence at sites 430-435 of Ag85a gene for coding the tubercle bacillus protein Ag85b. The invention provides a mosaic gene-containing mosaic tubercle bacillus gene vaccine, wherein the Ag85a gene is connected to a eukaryotic expression vector. The invention also provides a preparation method of the mosaic tubercle bacillus gene vaccine. The method comprises the following steps of: performing PCR (Polymerase Chain Reaction) amplification on an Ag85b gene segment; inserting the amplified Ag85b gene segment into the Ag85b gene-containing eukaryotic expression vector; and connecting by using ligase. The mosaic tubercle bacillus gene vaccine can be used for treating drug-resistant tubercle bacillus infection and can also be used in combination with levamisole serving as an adjuvantto induce stronger anti-tubercular cell immunological response.
Owner:GUAN DINGTAI HAIGUI BIOLOGICAL TECH CO LTD
Compound immunopotentiator, inactivated vaccine for poultry, and preparation method thereof
InactiveCN102793920AShorten the immune window periodHigh potencyOrganic active ingredientsViral antigen ingredientsAntigenLevamisole
The invention relates to a compound immunopotentiator and an application in preparation of veterinary vaccines. The compound immunopotentiator contains 0.5-100 microgram / mL of nucleic acid sequence with a CpG motif, 0.5-1000 microgram / mL of alpha-galactosyl ceramide, 5-2000 microgram / mL of beta-glucan, and 5-2000 microgram / mL of levomisole, wherein the nucleic acid sequence with a CpG motif is shown in SEQ ID NO.1. When the compound immunopotentiator of the invention is mixed with an H9-subtype avian influenza inactivated vaccine, the immune window period is shortened by 2 weeks; the antibody persistent period is prolonged by 8 weeks; sterilizing immunity protection is provided for H9-subtype homotype strain attack; and the antigen content for preparing vaccines is reduced.
Owner:JIANGSU ACAD OF AGRI SCI
Immunopotentiator for young portunus trituberculatus and application thereof
The invention discloses an immunopotentiator for a young portunus trituberculatus and an application thereof. The immunopotentiator is characterized by being prepared by evenly mixing the following raw materials in parts by weight: 10-15 parts of vitamin C, 5-10 parts of levamisole, 10-15 parts of astaxanthin, 10-20 parts of hypoxanthine nucleotide, 20-30 parts of beta-1,3-glucan, and 20-30 parts of seaweed polysaccharides. The mass percentage content of the immunopotentiator in a feeding feed is 0.06-0.08%. The immunopotentiator has the advantages that: the addition amount of the immunopotentiator in the feed is only 0.06-0.08%, thus the immunity and the disease resistance of the young portunus trituberculatus are significantly improved, so as to improve the survival rate of breeding portunus trituberculatus, wherein the survival rate can be increased by 25% or more, and the immune protection rate can reach 50% or more; and the immunopotentiator has no toxic or side effect, no residue and no drug resistance, also has no adverse effect on the feed palatability, has less addition amount, and can significantly improve the efficacy of the immunity and the disease resistance of the young portunus trituberculatus.
Owner:NINGBO UNIV
Animal immune activin and production method thereof
The invention relates to animal immune activin and a production method thereof. The production method comprises the following steps of: proportionally weighting, mixing, subpackaging, detecting and storing 30-80 percent of astragalus polyose, 5-10 percent of ganoderan, 10-20 percent of yeast and 0.1-1 percent of vamisole and carrier. The invention adjusts and balances various nutrient substances in multiple aspects, has scientific composition and can fully satisfy the animal immunity requirement. Several nutrient factors added in the animal immune activin have favorable mutual coordination action, can exert immunity adjustment action from different angles, overcome the efficacy insufficiency of single one or two substance addition and can generate better coordination effect. Compared witha product added with traditional Chinese medicines, the invention has the obvious advantages of rapid and accurate curative effect, little addition, and the like.
Owner:北京兴潮生物技术有限公司
Stable veterinary combination formulations of macrocyclic lactones and imidazothiazoles
ActiveUS20160051524A1Improve stabilityImprove solubilityBiocidePharmaceutical delivery mechanismAntiparasite agentControl parasites
The present invention is directed to stabilized compositions comprising at least one macrocyclic lactone, or derivative thereof, in combination with levamisole, and an amino sugar stabilizing agent, optionally an additional antiparasitic agent, and a method for treating or controlling a parasitic infection or infestation in an animal by administering said composition.
Owner:ZOETIS SERVICE LLC
Novel disease-resistant additive for adult procambarus clarkii shrimps and preparation method of novel disease-resistant additive
InactiveCN107996888AStimulate immune functionImprove immunityFodderClimate change adaptationDiseaseProcambarus clarkii
The invention discloses a novel disease-resistant additive for adult procambarus clarkii shrimps. The novel disease-resistant additive comprises the following components in parts by weight: 30-80 parts of a plant extraction polysaccharide compound, 20-50 parts of a yeast compound, 5-40 parts of levamisole, and 5-30 parts of sodium alginate, wherein the plant extraction polysaccharide compound comprises 30-40 parts of astragalus polysaccharide, 15-20 parts of bamboo shoot polysaccharide, and 20-25 parts of rice bran polysaccharide; and the yeast compound comprises 20-40 parts of yeast cell walls and 20-30 parts of selenium yeast. According to immunoenhancement components which are screened, not all the components having the best immunoenhancement properties are combined, while through comprehensive consideration of complementary characteristics, synergistic efficacy and immunoenhancement effects of the components, under the combined action of the components and within a specific contentrange, synergistic effects are achieved. The disease-resistant additive disclosed by the invention is added to the feed, so that the disease resistance of the adult shrimps can be obviously improved,the breeding survival rate can be increased, the breeding yield can be increased, and the mortality rate of the adult shrimps can be reduced. The water quality of a pond can be improved to a certainextent, the used raw material sources are stable to supply, and the production technology is simple.
Owner:GUANGDONG NUTRIERA GRP CO LTD +2
Scutellaria composite immune reinforcing agent, preparation method thereof and application thereof
InactiveCN101642488AOrganic active ingredientsClimate change adaptationWhite spot syndromeMortality rate
The technology belongs to the technical field of aquiculture disease prevention, in particular to the preparation method of the immune reinforcing agent for cultivating crustacean, and the applicationmethod thereof. The aquiculture composite immune reinforcing agent comprises 2-4 parts of aquiculture extractive or baicalin and 2.5-5 parts of levamisole. The composite immune reinforcing agent caneffectively enhance non-specific immunity for cultivating blue crab, improve the activity of the blood serum phenol oxidase, the superoxide dismutase and the alkalinephosphatase of the blue crab, andimproves the disease resistance of the blue crab to common pathogens such as white spot syndrome virus, vibrio, hematodinium, etc. The composite immune reinforcing agent can be applied to the cultivation of the blue crab by being injected or added into blue crab fresh fish bait and granulated feed for preventing and controlling the disease at the disease peak and reducing the disease rate and themortality rate of the blue crab. The immune reinforcing agent is added into the feed for preventing and controlling the disease of the penaeus vannamei boone and exopalaemon carinicauda.
Owner:ZHEJIANG INST OF FRESH WATER FISHERIES
Medicine composition used for controlling poultry airsacculitis, and preparation method thereof
The invention belongs to the field of veterinary drugs, and discloses a medicine composition used for controlling poultry airsacculitis. The composition is composed of the components of, by weight: 10-20% of aesculetin, 10-20% of deoxycycline, 10-20% of colistine sulfate, 2-5% of levamisole, 10-30% of vitamin C, 0.01-0.015% of dexamethasone, and balance of auxiliary materials. The invention also provides a preparation method of the medicine composition. The medicine composition provided by the invention has high effect against poultry airsacculitis, wherein an effective rate can be higher than 95%. The medicine composition is also advantaged in fast effect. In a first day of medication, a substantial effect can be provided, and the disease can be cured in 4 days. Also, the medicine composition has a wide antimicrobial spectrum. The medicine composition has excellent killing effects against poultry airsacculitis pathogens such as Escherichia coli, mycoplasma, pseudomonas aeruginosa, and the like. The medicine composition can effectively control secondary bacterial infections. Further, the medicine composition provided by the invention is advantaged in simple production method and convenient application. The production method is labor-saving.
Owner:NANJING AGRICULTURAL UNIVERSITY +1
Method for quickly screening stichopus japonicus immune enhancers with high throughput
The invention discloses a method for quickly screening stichopus japonicus immune enhancers with high throughput, which is characterized by comprising the following steps: firstly determining beta-glucan, peptidoglycan, chitosan, mannan-oligosaccharide, CpG-oligodeoxynucleotide, soy peptide, lactoferrin, levamisole, vitamin C and vitamin E as the screened immune enhancers, then carrying out primary culture for stichopus japonicus coelom cells, detecting four sensitive immune indexes of the immune enhancers on stichopus japonicus by the cultured stichopus japonicus coelom cells, namely effects of phagotrophy rate, superoxide anion content, superoxide dismutase activity and nitric oxide synthase activity, and determining a screening result for the effects of the four indexes according to the immune enhancers. The method can screen the immune enhancers on large scale and in short time, and simultaneously can research the action mechanisms of the various immune enhancers and lay a foundation for the deep study of the immune enhancers.
Owner:OCEAN UNIV OF CHINA
Vaccine diluent and preparing method and application thereof
InactiveCN106466295ASimple methodEasy to operateSsRNA viruses negative-senseOrganic active ingredientsDiseaseSwine Transmissible Gastroenteritis
The invention relates to the field of animal biological products, in particular to a vaccine diluent and a preparing method and application thereof. The vaccine diluent is prepared from 0.1-100g / L Carbomer and 0.1-200g / L levamisole; the adopted solvent is any one kind of water, normal saline or phosphate buffer. The vaccine diluent can solve the problems that a neutralizing antibody is low in potency after a vaccine is immunized, long in producing time and short in antibody maintenance time, and can be matched with a livestock and poultry attenuated live vaccine to use, such as a single vaccine or a mixed vaccine of viral vaccines of a swine fever live vaccine, a swine pseudorabies live vaccine, a porcine reproductive and respiratory syndrome live vaccine, a porcine epizootic diarrhea live vaccine, a swine transmissible gastroenteritis live vaccine, a porcine rotavirus disease live vaccine, a fowl pox live vaccine, a new castle disease live vaccine and the like.
Owner:SICHUAN HUASHEN ANIMAL BIOLOGICAL PRODS
Vaccine adjuvant and application thereof in preparation of Newcastle disease inactivating vaccine
ActiveCN104667273ALocal noneReactivity NoneViral antigen ingredientsAntiviralsNewcastle disease virus NDVLevamisole
The invention discloses a vaccine adjuvant and an application thereof in preparation of a Newcastle disease inactivating vaccine, and belongs to the field of the preparation of a Newcastle disease inactivating vaccine. The invention discloses a method for preparing the Newcastle disease inactivating vaccine by virtue of the vaccine adjuvant. The method comprises the following steps: (1) proliferating Newcastle disease viruses, collecting a virus solution and inactivating the virus solution; (2) adding a levomisole mother liquid to the inactivated virus mother liquid and uniformly mixing so as to obtain an aqueous phase solution; (3) adding a surfactant to the aqueous phase solution and uniformly mixing; and (4) adding white oil and emulsifying so as to obtain the Newcastle disease inactivating vaccine. The Newcastle disease inactivating vaccine prepared by the method disclosed by the invention is good in safety, and the vaccine can stimulate a body to generate relatively strong cellular immunity and humoral immunity and prolong the immune protection period thereof.
Owner:JILIN ZHENGYE BIOLOGICAL PROD
Compound preparation for treating cecal granuloma and preparation method thereof
InactiveCN105920081AEffective expansionLittle side effectsPeptide/protein ingredientsDigestive systemIntestinal wallsChlorogenic acid
The invention discloses a compound preparation for treating cecal granuloma and a preparation method thereof. The compound preparation comprises chloroquine phosphate, diiodohydroxyquinoline, chlorogenic acid, liquiritin, cistanoside, ursolic acid, polysavone, levamisole, albendazole, okra powder, lactein, vitamin B1, lactalbumin and arginine. The compound preparation can effectively expand intestinal tubes, prevent intestinal obstruction, prevent mesentery and intestinal wall inflammatory infiltration and edema, prevent intestinal wall fibrosis, adjust body metabolism, improve immunity, reduce drug side effects and treat cecal granuloma and has a wide application prospect.
Owner:于爱华
Immunopotentiator for adult portunus trituberculatus and application thereof
The invention discloses an immunopotentiator for an adult portunus trituberculatus and an application thereof. The immunopotentiator is characterized by being prepared by evenly mixing the following raw materials in parts by weight: 5-10 parts of levamisole, 15-20 parts of astaxanthin, 10-20 parts of hypoxanthine nucleotide, 20-30 parts of beta-1,3-glucan, and 30-40 parts of seaweed polysaccharides. The mass percentage content of the immunopotentiator in a feeding feed is 0.06-0.08%. The immunopotentiator has the advantages that: the addition amount of the immunopotentiator in the feed is only 0.06-0.08%, thus the immunity and the disease resistance of the adult portunus trituberculatus are significantly improved, so as to improve the survival rate of breeding portunus trituberculatus, wherein the survival rate can be increased by 26% or more, and the immune protection rate can reach 59% or more; and the immunopotentiator has no toxic or side effect, no residue and no drug resistance, also has no adverse effect on the feed palatability, has less addition amount, and can significantly improve the efficacy of the immunity and the disease resistance of the adult portunus trituberculatus.
Owner:NINGBO UNIV
Compound slow-releasing immune enhancer for cock
InactiveCN1895266APromote growthImprove disease resistanceOrganic active ingredientsPharmaceutical non-active ingredientsEpoxyEpimedium
A slow-releasing compound immunopotentiator for chicken is proportionally prepared from the medicinal components including astragalus polyose, epimedium polyose, levamisole, VE and sodium selenite, and the matrix components including epoxy resin, ethyldiamine, dibutyl phthalate and talc powder. Its preparing process is also disclosed.
Owner:GANSU ANIMAL HUSBANDRY & VETERINARY MEDICINE INST
Antibacterial and antiviral traditional Chinese medicine preparation for poultry and preparation method thereof
InactiveCN102552726ASatisfy the thirstImprove disease resistanceAntibacterial agentsAntiviralsWestern medicinePoultry product
The invention discloses an antibacterial and antiviral traditional Chinese medicine preparation for poultry, which is characterized by being composed of the following components: 110-130 parts of gypsum, 28-32 parts of radix rehmanniae, 59-61 parts of buffalo horn, 19-21 parts of coptis, 28-32 parts of Gardenia, 19-21 parts of tree peony bark, 24-26 parts of radix scutellariae, 24-26 parts of red paeonia, 24-26 parts of figwort, 28-32 parts of rhizoma anemarrhenae, 28-32 parts of forsythia, 24-26 parts of balloonflower, 14-16 parts of licorice, 24-26 parts of lophatherum, 10-20 parts of goldenrod and 5-15 parts of levamisole. The traditional Chinese medicine preparation is nontoxic, harmless and pollution-free, can effectively improve the antibacterial and antiviral capabilities of the poultry, can effectively replace antiviral Western medicines so as to provide pollution-free livestock and poultry products for the society, is lower in cost and is convenient for industrial popularization.
Owner:中科鑫洋(江苏)生物技术有限公司
Oral attenuated lyophilized vaccine for swine fever and preparation method thereof
InactiveCN108969492AEasy to takeGood immune effectPowder deliverySsRNA viruses positive-senseLevamisoleDryVax vaccine
The invention relates to an oral attenuated lyophilized vaccine for swine fever, which comprises a swine fever attenuated virus, a lyoprotectant and a vaccine diluent, wherein the vaccine diluent is prepared from a mucosal immune adjuvant and an immunopotentiator, and the mucosal immune adjuvant is prepared from a propolis extract, levamisole and carbomer; the immunopotentiator is prepared from astragalus polysaccharide and polygonatum polysaccharide. The oral attenuated lyophilized vaccine for the swine fever having a good immune effect is prepared by taking a attenuated strain of swine feveras a virus seed, and improving the lyoprotectant and the vaccine diluent, the vaccine can realize the complete protection of strong virulent virus of swine fever, generates higher antibody titer, hasbetter / comparative immune effects compared with commercially available inject vaccinate, and is convenient to use.
Owner:张志刚
Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and/or milbemycine
Veterinarian composition comprising an organic salt of levamisole in combination with at least one avermectine and / or milbemycine. A veterinarian formulation comprising of organics salts of levamisole, more specifically to the disophenolat salt of levamisole and the nitroxynil-salt of levamisole with avermectines and milbemycines and its use in treatment of helminthiasis in mammals, in particular in bovines, swines, caprines, equines, ovines, canines and felines.
Owner:NPA NUCLEO DE PESQUISAS APLICADAS LTDA +1
Injectable parasiticidal formulations of levamisole and macrocyclic lactones
InactiveUS20110281920A1Effective treatmentEffective prophylaxisBiocideOrganic active ingredientsMammalLevamisole
The present invention provides levamisole / macrocyclic lactone-containing injectable formulations that are effective against animal pests, including endoparasites. The formulations may be used for combating parasites in or on birds and mammals. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation of birds and mammals.
Owner:MERIAL LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com